Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase

Abstract

An unanticipated severe neurologic disorder occurred after ingestion of BIA 10-2474 at the highest dose level used in a phase 1 trial. The underlying mechanism of this toxic cerebral syndrome remains unknown.